NCT05549297 2026-02-25Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)Immunocore LtdPhase 3 Recruiting540 enrolled
NCT05785754 2025-06-26DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid TumorsDynamiCure BiotechnologyPhase 1 Recruiting320 enrolled